Ratings by Goldman Sachs (Salveen Richter)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/24/2021 TCR2 Therapeutics TCRR New Coverage Buy
(N/A)
17.24
(17.81)
3.31% Details
6/22/2021 Centessa Pharmaceuticals CNTA New Coverage Buy
(N/A)
24.91
(23.75)
-4.66% Details
5/24/2021 Reata Pharmaceuticals RETA New Coverage Buy
(N/A)
111.60
(147.96)
32.58% Details
5/20/2021 Precision BioSciences Inc. DTIL Maintain Neutral
(N/A)
 
 
  Details
5/14/2021 4D Molecular Therapeutics FDMT Maintain Neutral
(N/A)
 
 
  Details
5/11/2021 Recursion Pharmaceuticals RXRX New Coverage Neutral
(N/A)
27.73
(34.76)
25.35% Details
5/10/2021 Amicus Therapeutics FOLD Maintain Neutral
(N/A)
 
 
  Details
5/4/2021 Incyte INCY Maintain Buy
(N/A)
 
 
  Details
5/4/2021 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
5/3/2021 Agios Pharma AGIO New Coverage Neutral
(N/A)
55.78
(57.10)
2.37% Details
4/29/2021 Blueprint Medicines BPMC Maintain Buy
(N/A)
 
 
  Details
4/6/2021 Acadia Pharmaceuticals ACAD Downgrade Neutral
(Buy)
25.59
(25.05)
-2.11% Details
3/28/2021 4D Molecular Therapeutics FDMT Maintain Neutral
(Neutral)
 
 
  Details
3/25/2021 Sana Biotechnology SANA Maintain Neutral
(Neutral)
 
 
  Details
3/18/2021 Precision BioSciences Inc. DTIL Maintain Neutral
(N/A)
 
 
  Details
3/4/2021 Taysha Gene Therapies TSHA Maintain Buy
(Buy)
 
 
  Details
3/4/2021 Passage Bio Inc. PASG Upgrade Buy
(Neutral)
19.59
(14.12)
-27.92% Details
3/3/2021 Adeptus Biotechnologies Corp. ADPT Downgrade Neutral
(Buy)
53.11
(39.70)
-25.25% Details
3/2/2021 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
3/2/2021 uniQure BV QURE Maintain Buy
(Buy)
 
 
  Details
3/1/2021 Madrigal Pharmaceuticals MDGL Maintain Neutral
(Neutral)
 
 
  Details
3/1/2021 Denali Therapeutics Inc. DNLI Maintain Buy
(Buy)
 
 
  Details
3/1/2021 Sana Biotechnology SANA New Coverage Neutral
(N/A)
32.05
(20.21)
-36.94% Details
2/26/2021 Mirati Therapeutics MRTX Maintain Buy
(Buy)
 
 
  Details
2/26/2021 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
2/25/2021 Karuna Therapeutics Inc. KRTX Maintain Buy
(N/A)
 
 
  Details
2/25/2021 Acadia Pharmaceuticals ACAD Maintain Buy
(N/A)
 
 
  Details
2/24/2021 bluebird bio BLUE Maintain Buy
(N/A)
 
 
  Details
2/18/2021 bluebird bio BLUE Maintain Buy
(N/A)
 
 
  Details
2/17/2021 CRISPR Therapeutics CRSP Maintain Neutral
(N/A)
 
 
  Details
12/21/2020 Moderna MRNA Maintain Buy
(N/A)
 
 
  Details
11/24/2020 Alnylam Pharmaceuticals ALNY Maintain Neutral
(N/A)
 
 
  Details
11/17/2020 Intellia Therapeutics NTLA Maintain Buy
(N/A)
 
 
  Details
11/10/2020 Denali Therapeutics Inc. DNLI Maintain Buy
(N/A)
 
 
  Details
11/9/2020 Cellectis CLLS Maintain Sell
(N/A)
 
 
  Details
11/6/2020 Madrigal Pharmaceuticals MDGL Maintain Neutral
(N/A)
 
 
  Details
11/6/2020 Denali Therapeutics Inc. DNLI Maintain Buy
(N/A)
 
 
  Details
11/4/2020 Allogene ALLO Maintain Buy
(N/A)
 
 
  Details
10/29/2020 Moderna MRNA Maintain Buy
(N/A)
 
 
  Details
10/28/2020 CRISPR Therapeutics CRSP Maintain Neutral
(N/A)
 
 
  Details
10/21/2020 CRISPR Therapeutics CRSP Maintain Neutral
(N/A)
 
 
  Details
10/19/2020 Taysha Gene Therapies TSHA New Coverage Neutral
(N/A)
21.05
(25.19)
19.67% Details
10/16/2020 Denali Therapeutics Inc. DNLI Maintain Buy
(N/A)
 
 
  Details
9/21/2020 Moderna MRNA Maintain Buy
(N/A)
 
 
  Details
9/18/2020 Intellia Therapeutics NTLA New Coverage Buy
(N/A)
22.45
(85.46)
280.67% Details
9/8/2020 Blueprint Medicines BPMC Maintain Buy
(N/A)
 
 
  Details
8/20/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Conviction Buy
(N/A)
 
 
  Details
8/19/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Conviction Buy
(N/A)
 
 
  Details
8/13/2020 Precision BioSciences Inc. DTIL Maintain Neutral
(N/A)
 
 
  Details
8/11/2020 Adeptus Biotechnologies Corp. ADPT Maintain Buy
(N/A)
 
 
  Details
8/11/2020 Denali Therapeutics Inc. DNLI Maintain Buy
(N/A)
 
 
  Details
8/10/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
8/10/2020 Denali Therapeutics Inc. DNLI Maintain Buy
(N/A)
 
 
  Details
8/10/2020 Relay Therapeutics RLAY New Coverage Buy
(N/A)
41.02
(35.61)
-13.19% Details
8/6/2020 bluebird bio BLUE Maintain Buy
(N/A)
 
 
  Details
8/6/2020 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
7/31/2020 uniQure BV QURE Maintain Buy
(N/A)
 
 
  Details
6/29/2020 Intercept Pharmaceuticals ICPT Downgrade Neutral
(Buy)
77.49
(21.18)
-72.67% Details
6/25/2020 Passage Bio Inc. PASG Downgrade Neutral
(Buy)
36.07
(14.12)
-60.85% Details
6/3/2020 Adeptus Biotechnologies Corp. ADPT New Coverage Buy
(N/A)
39.07
(39.70)
1.61% Details
6/1/2020 Karuna Therapeutics Inc. KRTX Maintain Buy
(N/A)
 
 
  Details
5/29/2020 Allogene ALLO Maintain Buy
(N/A)
 
 
  Details
5/26/2020 Incyte INCY Downgrade Buy
(Conviction Buy)
99.37
(85.41)
-14.05% Details
5/26/2020 Seattle Genetics SGEN Upgrade Conviction Buy
(Buy)
155.77
(156.26)
0.31% Details
5/18/2020 Moderna MRNA Maintain Buy
(N/A)
 
 
  Details
5/8/2020 Arrowhead Research ARWR Maintain Neutral
(N/A)
 
 
  Details
4/28/2020 Blueprint Medicines BPMC Maintain Buy
(N/A)
 
 
  Details
4/21/2020 Madrigal Pharmaceuticals MDGL Maintain Neutral
(N/A)
 
 
  Details
4/16/2020 Mirati Therapeutics MRTX New Coverage Buy
(N/A)
85.32
(165.90)
94.44% Details
4/3/2020 Precision BioSciences Inc. DTIL Downgrade Neutral
(Buy)
5.27
(11.30)
114.42% Details
3/31/2020 Acadia Pharmaceuticals ACAD Upgrade Buy
(Neutral)
38.83
(25.59)
-34.1% Details
3/26/2020 bluebird bio BLUE Maintain Buy
(N/A)
 
 
  Details
3/24/2020 Karuna Therapeutics Inc. KRTX Maintain Buy
(N/A)
 
 
  Details
3/17/2020 Arrowhead Research ARWR New Coverage Neutral
(N/A)
26.32
(89.23)
239.02% Details
3/6/2020 Cellectis CLLS Downgrade Sell
(Neutral)
15.74
(15.42)
-2.03% Details
2/28/2020 Denali Therapeutics Inc. DNLI Maintain Buy
(N/A)
 
 
  Details
2/27/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
2/27/2020 Moderna MRNA Maintain Buy
(N/A)
 
 
  Details
2/25/2020 Intercept Pharmaceuticals ICPT Maintain Buy
(N/A)
 
 
  Details
2/14/2020 CRISPR Therapeutics CRSP Maintain Neutral
(N/A)
 
 
  Details
2/14/2020 Agios Pharma AGIO Maintain Neutral
(N/A)
 
 
  Details
2/13/2020 CRISPR Therapeutics CRSP Maintain Neutral
(N/A)
 
 
  Details
2/11/2020 Seattle Genetics SGEN Maintain Buy
(N/A)
 
 
  Details
2/6/2020 Alnylam Pharmaceuticals ALNY Maintain Neutral
(N/A)
 
 
  Details
1/27/2020 Denali Therapeutics Inc. DNLI Upgrade Buy
(Neutral)
24.90
(73.80)
196.39% Details
1/3/2020 Incyte INCY Maintain Conviction Buy
(N/A)
 
 
  Details
12/24/2019 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
12/3/2019 uniQure BV QURE New Coverage Buy
(N/A)
54.78
(30.19)
-44.89% Details
11/21/2019 Alnylam Pharmaceuticals ALNY Maintain Neutral
(N/A)
 
 
  Details
11/19/2019 CRISPR Therapeutics CRSP Maintain Neutral
(N/A)
 
 
  Details
11/18/2019 Karuna Therapeutics Inc. KRTX Maintain Buy
(N/A)
 
 
  Details
11/13/2019 Solid Biosciences SLDB Maintain Sell
(N/A)
 
 
  Details
11/11/2019 Cellectis CLLS Maintain Neutral
(N/A)
 
 
  Details
10/23/2019 Seattle Genetics SGEN Maintain Buy
(N/A)
 
 
  Details
10/22/2019 Seattle Genetics SGEN Maintain Buy
(N/A)
 
 
  Details
10/21/2019 Agios Pharma AGIO Maintain Neutral
(N/A)
 
 
  Details
10/21/2019 Acorda Therapeutics, Inc. ACOR Maintain Sell
(N/A)
 
 
  Details
9/27/2019 Atara Biotherapeutics ATRA Downgrade Sell
(Neutral)
14.29
(16.04)
12.25% Details
9/27/2019 Seattle Genetics SGEN Upgrade Buy
(Conviction Sell)
73.62
(155.77)
111.59% Details
9/3/2019 Vertex VRTX Upgrade Conviction Buy
(Buy)
180.02
(192.87)
7.14% Details
8/20/2019 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
8/12/2019 Cellectis CLLS Maintain Neutral
(N/A)
 
 
  Details
7/23/2019 Karuna Therapeutics Inc. KRTX New Coverage Buy
(N/A)
19.69
(127.06)
545.3% Details
5/28/2019 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
 
 
  Details
5/23/2019 Alexion Pharmaceuticals ALXN New Coverage Neutral
(N/A)
128.80
(181.95)
41.27% Details
5/23/2019 Vertex VRTX New Coverage Buy
(N/A)
169.12
(180.02)
6.45% Details
5/23/2019 Alnylam Pharmaceuticals ALNY New Coverage Neutral
(N/A)
67.87
(175.61)
158.74% Details
5/23/2019 Agios Pharma AGIO New Coverage Neutral
(N/A)
51.36
(57.10)
11.18% Details
5/23/2019 Blueprint Medicines BPMC New Coverage Buy
(N/A)
78.97
(84.89)
7.5% Details
5/14/2019 Solid Biosciences SLDB Downgrade Sell
(Neutral)
8.85
(3.84)
-56.61% Details
5/7/2019 GW Pharma GWPH Maintain Buy
(N/A)
 
 
  Details
4/22/2019 Precision BioSciences Inc. DTIL New Coverage Buy
(N/A)
12.18
(5.27)
-56.73% Details
1/28/2019 CRISPR Therapeutics CRSP Downgrade Neutral
(Buy)
32.29
(137.06)
324.47% Details
1/15/2019 Incyte INCY Upgrade Conviction Buy
(Buy)
74.65
(99.37)
33.11% Details
1/2/2019 Moderna MRNA New Coverage Buy
(N/A)
15.27
(225.14)
1374.39% Details
12/26/2018 Acorda Therapeutics, Inc. ACOR Maintain Sell
(N/A)
 
 
  Details
12/19/2018 Cellectis CLLS New Coverage Neutral
(N/A)
17.71
(15.74)
-11.12% Details
12/11/2018 Acorda Therapeutics, Inc. ACOR Downgrade Sell
(Neutral)
18.63
(5.13)
-72.46% Details
11/5/2018 Allogene ALLO New Coverage Buy
(N/A)
26.95
(24.02)
-10.87% Details
9/21/2018 bluebird bio BLUE Downgrade Buy
(Conviction Buy)
141.30
(32.25)
-77.18% Details
9/19/2018 Madrigal Pharmaceuticals MDGL Maintain Buy
(Buy)
 
 
  Details
8/28/2018 Ionis Pharmaceuticals IONS Maintain Sell
(Sell)
 
 
  Details